Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.
J Clin Endocrinol Metab. 2011 Dec;96(12):E2078-87. doi: 10.1210/jc.2011-1401. Epub 2011 Oct 5.
We report hereditary pituitary hyperplasia.
The objective of the study was to describe the results of the clinical and laboratory analysis of this rare instance of hereditary pituitary hyperplasia.
The study is a retrospective analysis of three cases from one family.
The study was conducted at the National Institutes of Health, a tertiary referral center.
A mother and both her sons had very early-onset gigantism associated with high levels of serum GH and prolactin.
The condition was treated by total hypophysectomy.
MAIN OUTCOME MEASURE(S): We performed clinical, pathological, and molecular evaluations, including evaluation basal and provocative endocrine testing, neuroradiological assessment, and assessment of the pituitary tissue by microscopic evaluation, immunohistochemistry, and electron microscopy.
All three family members had very early onset of gigantism associated with abnormally high serum levels of GH and prolactin. Serum GHRH levels were not elevated in either of the boys. The clinical, radiographic, surgical, and histological findings indicated mammosomatotroph hyperplasia. The pituitary gland of both boys revealed diffuse mammosomatotroph hyperplasia of the entire pituitary gland without evidence of adenoma. Prolactin and GH were secreted by the same cells within the same secretory granules. Western blot and immunohistochemistry demonstrated expression of GHRH in clusters of cells distributed throughout the hyperplastic pituitary of both boys.
This hereditary condition seems to be a result of embryonic pituitary maldevelopment with retention and expansion of the mammosomatotrophs. The findings suggest that it is caused by paracrine or autocrine pituitary GHRH secretion during pituitary development.
我们报告一例遗传性垂体增生。
本研究的目的是描述这例罕见遗传性垂体增生的临床和实验室分析结果。
本研究是对来自一个家族的 3 例病例的回顾性分析。
研究在国立卫生研究院进行,这是一家三级转诊中心。
一位母亲和她的两个儿子都患有早发性巨大症,伴有血清 GH 和催乳素水平升高。
该疾病通过全垂体切除术进行治疗。
我们进行了临床、病理和分子评估,包括基础和激发内分泌测试评估、神经影像学评估,以及通过显微镜评估、免疫组织化学和电子显微镜评估垂体组织。
所有 3 位家族成员都患有早发性巨大症,伴有血清 GH 和催乳素水平异常升高。两个男孩的血清 GHRH 水平均未升高。临床、影像学、手术和组织学发现表明存在催乳生长激素细胞增生。两个男孩的垂体均显示整个垂体弥漫性催乳生长激素细胞增生,无腺瘤证据。催乳素和 GH 由同一分泌颗粒中的相同细胞分泌。Western blot 和免疫组织化学显示,两个男孩的增生垂体中均有 GHRH 表达于分布于整个增生垂体的细胞簇中。
这种遗传性疾病似乎是胚胎期垂体发育不良的结果,保留和扩大了催乳生长激素细胞。这些发现提示,它是由垂体发育过程中垂体 GHRH 的旁分泌或自分泌引起的。